Impact of D3 lymph node dissection on upstaging and short-term survival in clinical stage I right-sided colon cancer

Bibliographic Details
Title: Impact of D3 lymph node dissection on upstaging and short-term survival in clinical stage I right-sided colon cancer
Authors: Ji-Seon Kim, Se-Jin Baek, Jung-Myun Kwak, Jin Kim, Seon-Hahn Kim, Woong Bae Ji, Jung Sik Kim, Kwang Dae Hong, Jun Won Um, Sang Hee Kang, Sun Il Lee, Byung Wook Min
Source: Asian Journal of Surgery, Vol 44, Iss 10, Pp 1278-1282 (2021)
Publisher Information: Elsevier, 2021.
Publication Year: 2021
Collection: LCC:Surgery
Subject Terms: Central vascular ligation, Complete mesocolic excision, D3 lymph node dissection, Early colon cancer, Right-sided colon cancer, Surgery, RD1-811
More Details: Summary: Background: D3 lymph node dissection is becoming the standard procedure for the treatment of advanced right colon cancer and has shown increasing evidence of its oncologic benefit. However, a clear indication for its application is lacking and data on this topic is unsatisfactory. Thus, the necessity for D3 lymph node dissection in clinical stage I right colon cancer remains controversial. Methods: We retrospectively analyzed data from clinical stage I right colon cancer patients who underwent radical surgery at three hospitals of Korea university medical center between January 2015 and June 2018. We compared surgical complications and short-term oncologic outcomes between D2 and D3 lymph node dissections in these patients. Results: Among 512 patients, 122 (23.8%) were clinical stage I. Of these, 88 and 34 patients received D2 and D3 lymph node dissection, respectively. There were no statistically significant differences in clinicopathologic variables and surgical outcomes between the two groups. Upstaging occurred in 16 patients (47.1%) in the D3 group and 23 patients (26.1%) in the D2 group. There were four recurrences in the D2 group but no recurrence in the D3 group. Log-rank tests showed no statistically significant difference in disease-free survival rates between the two groups (p = 0.210). Conclusion: There was no significant difference in disease-free survival rates between D2 and D3 lymph node dissection in clinical stage I right colon cancer patients. However, recurrence occurred in the D2 group. Efforts to improve the accuracy of clinical staging are required and more studies with better quality are needed.
Document Type: article
File Description: electronic resource
Language: English
ISSN: 1015-9584
Relation: http://www.sciencedirect.com/science/article/pii/S1015958421001184; https://doaj.org/toc/1015-9584
DOI: 10.1016/j.asjsur.2021.02.011
Access URL: https://doaj.org/article/cd70dd7b50314738851cb0a491f393d6
Accession Number: edsdoj.70dd7b50314738851cb0a491f393d6
Database: Directory of Open Access Journals
More Details
ISSN:10159584
DOI:10.1016/j.asjsur.2021.02.011
Published in:Asian Journal of Surgery
Language:English